News 2023-07-28
[Important Notice] Porton Announcement Regarding the Change of Email Domain
Dear valued customers and partners,
We would like to extend our gratitude for your continuous support towards Porton Pharma Solutions Ltd. In order to further enhance the company's brand recognition, adapt to our global development strategy, improve communication efficiency, and protect each other's information security, we have decided to change our email domain name from porton.cn to portonpharma.com.
We will be discontinuing the use of the old email addresses and will automatically forward all emails sent to the old addresses to the new address in the coming weeks or so. To avoid any unnecessary delays, we strongly recommend that you start using the new email address to contact us starting from August 13, 2023.
We look forward to maintaining closer contact with you and achieving greater business success together. If you have any questions or need further assistance, please feel free to contact us at any time.
We apologize for any inconvenience caused by this change and appreciate your understanding!
Website: www. portonpharma.com
Others
More
News 2026-10-09
Porton Successfully Concludes CPHI Milan 2026, Showcasing Integrated CDMO Capabilities and Connecting for Global Pharma Innovation
Porton Pharma Solutions showcased its capabilities at the event, engaging in multiple face-to-face meetings with pharmaceutical and biotech companies and industry partners from Europe and around the world at Booth 10K6, discussing drug development trends, supply chain challenges, and diverse CDMO collaboration opportunities.

News 2026-09-30
Porton Newsletter - September, 2026 Recap
Porton Recognized by LyncBio Therapeutics for ADC Payload-Linker CMC Capabilities Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001 PMO Therapeutics: Technical Review and Manufacturing Platform Capabilities